Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

2008 Trends to Watch: Pharmaceutical Technology

Published by: Datamonitor

Published: Jan. 31, 2008 - 13 Pages


Table of Contents


DATAMONITOR VIEW
CATALYST
SUMMARY
ANALYSIS
The industry is plagued by generic competition due to blockbuster drugs coming off patent
The golden age of Big Pharma and blockbuster drugs is over
Mounting drug safety concerns puts pressure on regulatory bodies, especially the FDA
Pharmaceutical companies accuse the FDA of being overly-cautious
Pharmaceutical companies are restructuring their business models to adapt to the changing environment
The pharmaceutical industry turns to biotechnology for the next blockbuster
ACTIONS
Impact on the life science industry
It is essential for the life science industry to streamline operations
The pharmaceutical industry must embrace IT to shift away from the ""blockbuster drug"" business model
New regulations will require companies to have better data management
Recommendations for technology vendors
Vendors need to demonstrate that IT solutions will optimize business processes
IT vendors must prove their products will aid global market development
Customer focus is essential to penetrate the market
APPENDIX
Definitions
Methodology
Further reading
Ask the analyst
Datamonitor consulting
Disclaimer
List of Figures
Figure 1: Drug discovery & development process
Figure 2: Number of branded drugs going off patent between 2008-2012
Figure 3: Number of new molecular entities (NMEs) and biologics approved by the FDA, 1980-2007
Figure 4: Number of layoffs announced by Big Pharma in 2006-2007


Abstract

Introduction

Technology markets are changing fast. This brief identifies and tracks the key forces shaping the prospects for your business. In this piece, Datamonitor's analyst specializing in pharmaceutical technology will outline the changes in the market, explain which trends will have the biggest impact, and highlight who will benefit from the fast-paced developments in pharmaceutical technology.

Scope

An overview of the challenges facing the life science industry in 2008 Datamonitor's take on the technology priorities of pharmaceutical and biotechnology companies Strategies to help technology vendors penetrate the life science industry

Highlights

As the specter of generic competition grows, streamlining operations to reduce costs and time-to-market of a drug will be a top priority for pharmaceutical companies. The life science industry must embrace technology solutions as it shifts away from the blockbuster drug business model. Data management is a key issue affecting the life sciences. As drug regulatory agencies demand more clinical and post-market data, clinical IT solutions will become crucial to the industry.

Reasons to Purchase

Learn about the top trends in the life science industry in 2008 Identify strategies for expanding business opportunities in the life science industry Tailor your go-to-market strategy to address critical issues facing pharmaceutical and biotechnology companies.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008